Study #NRG-GI003
NRG-GI003: A Phase III Randomized Trial of Protons versus Photons for Hepatocellular Carcinoma
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This phase III trial studies how well radiation therapy with protons works compared with photons in treating patients with liver cancer. Radiation therapy, such as photon therapy, uses high energy x-rays to send the radiation inside the body to the tumor while proton therapy uses a beam of proton particles. Proton therapy can stop shortly after penetrating through the tumor and may cause less damage to the surrounding healthy organs and result in better survival in patients with liver cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Unrectable or Locally Recurrent Hepatocellular Carcinoma
Study phase:
Phase III
Physician name:
Eugene Koay
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.